 optim mute fear
strong execut ep guid achiev adj ep
est respect tp goe
risk macro auto electron hous pfoa litig
overarch theme play mix enrich
yet fire cylind capac limit bioactiv weak etc
seg growth higher margin product probiot cultur microbi
control track well benefit via probiot capac expans
progress ramp offer dd growth hsd growth
pharma provid margin accret growth engin well
post capac constraint augment stabil end market
view perform remain posit driver stock
earli return encourag numer lever pull
yr/yr margin expans promis sign support belief dd
execut synergi total qtr cost cut program
realiz plan mainten
turnaround mute nt benefit stress dd alreadi identifi
opportun site suppli chain consolid even weak resi
construct environ sustain growth water healthcar
safeti applic drive op leverag tyvek kevlar facil
challeng come surpris focu despit
align lt mega-trend de-stock poor demand memori
auto weigh result note incred well understood
nt see rel margin stabil sequenti improv
enough investor extend free pass balanc
nois abat lt opportun exist transact pension
expenditur dd retain wc improv lt horizon
radar nt expect buy-back supplement ep growth
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
dupont global leader specialti materi sell highli
differenti product four segment transport
construct iv nutrit bioscienc
price aug rate outperform target price analyst christoph parkinson
profit tax
chang work capit
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
grey scenario base ebitda
struggl improv margin expect due turbul
separ process depart fail launch new
products/appl caus dd top line drag
macro headwind addit assum issu caus dd
miss target limit abil return capit
scenario base ebitda
realiz upsid commun synergi target revenu etc
smoothli execut separ necessari portfolio action
continu releas new product support top line growth
addit assum dd achiev convers
target leav option buyback
 close
compani mention price
